Try our Advanced Search for more refined results

US Coverage

Law360 Authority | Deep News & Analysis

Global Coverage

Law360 Pulse | The Business of Law

Mealeys

MLex

November 21, 2018

Hull Leavitt v. Alnylam Pharmaceuticals, Inc. et al

Track this case

Case Number:

1:18-cv-12433

Court:

Massachusetts

Nature of Suit:

Securities/Commodities

Multi Party Litigation:

Class Action

Judge:

Nathaniel M. Gorton

Firms

Companies

Sectors & Industries:

View recent docket activity

Reflects complaints, answers, motions, orders and trial notes entered from Jan. 1, 2011.
Additional or older documents may be available in Pacer.

Coverage

  1. March 23, 2020

    Alnylam Dodges Stock-Drop Suit Over FDA Approval Efforts

    Alnylam Pharmaceuticals escaped a stock-drop suit Monday when a federal judge in Massachusetts dismissed investors' claims that the company made misleading statements about the FDA approval prospects for a drug to treat a rare disease.

1 other articles on this case. View all »

Parties

Stay ahead of the curve

In the legal profession, information is the key to success. You have to know what’s happening with clients, competitors, practice areas, and industries. Law360 provides the intelligence you need to remain an expert and beat the competition.


  • Direct access to case information and documents.
  • All significant new filings across U.S. federal district courts, updated hourly on business days.
  • Full-text searches on all patent complaints in federal courts.
  • No-fee downloads of the complaints and so much more!

TRY LAW360 FREE FOR SEVEN DAYS

View the parties now

Already a subscriber? Click here to login